{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:45:25Z","timestamp":1782301525862,"version":"3.54.5"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The epidemiological evidence on soft-tissue sarcoma (STS) mortality is inconsistent in geographic and time coverage. This study provides mortality trends for STSs in selected countries worldwide over the last 2 decades, together with predicted figures for 2025.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We extracted official numbers of certified deaths coded as C47 (i.e. malignant neoplasm of peripheral nerves and autonomic nervous system) and C49 (i.e. malignant neoplasm of other connective and soft tissue) according to the 10th Revision of the International Classification of Disease and population estimates from the WHO and the Pan American Health Organization databases. We computed age-standardized (world standard population) mortality rates (ASMRs). We used joinpoint regression analysis to identify significant changes in trends and to predict death numbers and rates for 2025.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The pattern emerging from the number of deaths and ASMRs up to 2018 shows an increase in most countries in both sexes. Around 2015 to 2018, ASMRs differed by 2.5-fold in both sexes with the highest rates being registered in Central-Eastern Europe, North America and Australia, while the lowest ones in Latin America, Japan, and Korea. In 2025, the number of STS deaths is predicted to increase in most countries and both sexes, and unfavourable rates are predicted in Central Europe in both sexes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In addition to improvements in STSs registration, unfavourable mortality rates reported in this study reflect inadequate referral of patients with STSs to high-volume multidisciplinary centres, as well as insufficient advancements in STS prevention, diagnosis, and treatments.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cej.0000000000000768","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T18:00:09Z","timestamp":1667930409000},"page":"71-80","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Mortality patterns of soft-tissue sarcomas worldwide up to 2018, with predictions for 2025"],"prefix":"10.1097","volume":"32","author":[{"given":"Margherita","family":"Pizzato","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan, Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Collatuzzo","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Santucci","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan, Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Malvezzi","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan, Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Boffetta","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy"},{"name":"Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Comandone","sequence":"additional","affiliation":[{"name":"Department of Oncology, San Giovanni Bosco Hospital, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Levi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Services Research, Unisant\u00e9, University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan, Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bertuccio","sequence":"additional","affiliation":[{"name":"Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Negri","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/jso.25052","article-title":"Improved survival for extremity soft tissue sarcoma treated in high-volume facilities.","volume":"117","author":"Abarca","year":"2018","journal-title":"J Surg Oncol"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1245\/s10434-021-09946-4","article-title":"Management of soft tissue sarcomas in extremities: variation in treatment recommendations and surveillance according to specialty and continent.","volume":"28","author":"Acem","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"R1a-20250527","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/jso.25052","article-title":"Improved survival for extremity soft tissue sarcoma treated in high-volume facilities.","volume":"117","author":"Abarca","year":"2018","journal-title":"J Surg Oncol"},{"key":"R2a-20250527","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1245\/s10434-021-09946-4","article-title":"Management of soft tissue sarcomas in extremities: variation in treatment recommendations and surveillance according to specialty and continent.","volume":"28","author":"Acem","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.critrevonc.2016.12.002","article-title":"ECCO essential requirements for quality cancer care: soft tissue sarcoma in adults and bone sarcoma. a critical review.","volume":"110","author":"Andritsch","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2045-3329-2-18","article-title":"Sarcoma risk after radiation exposure.","volume":"2","author":"Berrington de Gonzalez","year":"2012","journal-title":"Clin Sarcoma Res"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/annonc\/mdz179","article-title":"Cancer mortality in Europe in 2015 and an overview of trends since 1990.","volume":"30","author":"Bertuccio","year":"2019","journal-title":"Ann Oncol"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"101590","DOI":"10.1016\/j.canep.2019.101590","article-title":"A population-based study of soft tissue sarcoma incidence and survival in Australia: an analysis of 26,970 cases.","volume":"63","author":"Bessen","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/annonc\/mdx484","article-title":"Improved survival using specialized multidisciplinary board in sarcoma patients.","volume":"28","author":"Blay","year":"2017","journal-title":"Ann Oncol"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/cncr.20995","article-title":"National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation.","volume":"103","author":"Bleyer","year":"2005","journal-title":"Cancer"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00008469-200310000-00012","article-title":"Occupational exposure to vinyl chloride and cancer risk: a review of the epidemiologic literature.","volume":"12","author":"Bosetti","year":"2003","journal-title":"Eur J Cancer Prev"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2045-3329-2-14","article-title":"The epidemiology of sarcoma.","volume":"2","author":"Burningham","year":"2012","journal-title":"Clin Sarcoma Res"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"iv79","DOI":"10.1093\/annonc\/mdy310","article-title":"Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up.","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJMra041866","article-title":"Soft-tissue sarcomas in adults.","volume":"353","author":"Clark","year":"2005","journal-title":"N Engl J Med"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/sim.3733","article-title":"Estimating average annual per cent change in trend analysis.","volume":"28","author":"Clegg","year":"2009","journal-title":"Stat Med"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.ejso.2019.11.518","article-title":"Soft tissue sarcoma in children, adolescents and young adults: outcomes according to compliance with international initial care guidelines.","volume":"46","author":"Collignon","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3322\/canjclin.54.2.94","article-title":"Soft tissue sarcomas.","volume":"54","author":"Cormier","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"e2100387","DOI":"10.1200\/GO.21.00387","article-title":"Overview of adult sarcoma burden and clinical pathways in Brazil.","author":"David","year":"2022","journal-title":"JCO Global Oncol"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s12094-020-02534-0","article-title":"SEOM clinical guideline of management of soft-tissue sarcoma (2020).","volume":"23","author":"de Juan Ferr\u00e9","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"e20294","DOI":"10.1371\/journal.pone.0020294","article-title":"Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing.","volume":"6","author":"Ducimeti\u00e8re","year":"2011","journal-title":"PLoS One"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/s12885-021-08393-4","article-title":"Determinants of the access to remote specialised services provided by national sarcoma reference centres.","volume":"21","author":"Fayet","year":"2021","journal-title":"BMC Cancer"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.18632\/oncotarget.26809","article-title":"Sarcomas in the United States: recent trends and a call for improved staging.","volume":"10","author":"Gage","year":"2019","journal-title":"Oncotarget"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3322\/caac.21605","article-title":"Soft-tissue sarcoma in adults: an update on the current state of histiotype-specific management in an era of personalized medicine.","volume":"70","author":"Gamboa","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jor.2021.03.021","article-title":"Epidemiological profile of soft tissue sarcomas of the extremities: incidence, histological subtypes, and primary sites.","volume":"25","author":"Garc\u00eda-Ortega","year":"2021","journal-title":"J Orthop"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JCO.2017.75.9845","article-title":"Soft tissue and uterine leiomyosarcoma.","volume":"36","author":"George","year":"2018","journal-title":"J Clin Oncol"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up\u2606.","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1245\/s10434-016-5158-7","article-title":"Worse survival in elderly patients with extremity soft-tissue sarcoma.","volume":"23","author":"Hoven-Gondrie","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.4143\/crt.2018.476","article-title":"Characteristics and treatment patterns of patients with advanced soft tissue sarcoma in Korea.","volume":"51","author":"Kim","year":"2019","journal-title":"Cancer Res Treat"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"101596","DOI":"10.1016\/j.canep.2019.101596","article-title":"Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015.","volume":"63","author":"Koll\u00e1r","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/annonc\/mdp530","article-title":"Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975.","volume":"21","author":"La Vecchia","year":"2010","journal-title":"Ann Oncol"},{"key":"R34-20250527","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0959-8049(05)80091-7","article-title":"Trends of cancer mortality in Europe, 1955-1989: II, respiratory tract, bone, connective and soft tissue sarcomas, and skin.","volume":"28","author":"La Vecchia","year":"1992","journal-title":"Eur J Cancer"},{"key":"R35-20250527","doi-asserted-by":"crossref","first-page":"e030013","DOI":"10.1136\/bmjopen-2019-030013","article-title":"ETIOSARC study: environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol.","volume":"9","author":"Lacourt","year":"2019","journal-title":"BMJ Open"},{"key":"R36-20250527","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0959-8049(99)00179-3","article-title":"Descriptive epidemiology of soft tissue sarcomas in Vaud, Switzerland.","volume":"35","author":"Levi","year":"1999","journal-title":"Eur J Cancer"},{"key":"R37-20250527","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ejca.2003.03.001","article-title":"Trends in cancer mortality at age 15 to 24 years in Europe.","volume":"39","author":"Levi","year":"2003","journal-title":"Eur J Cancer"},{"key":"R38-20250527","doi-asserted-by":"crossref","first-page":"e562","DOI":"10.1016\/S1470-2045(13)70475-3","article-title":"Management of sarcoma in the Asia-Pacific region: resource-stratified guidelines.","volume":"14","author":"Lewin","year":"2013","journal-title":"Lancet Oncol"},{"key":"R39-20250527","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1002\/cncr.27555","article-title":"Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions.","volume":"118","author":"Mastrangelo","year":"2012","journal-title":"Cancer"},{"key":"R40-20250527","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/annonc\/mdt407","article-title":"Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based study\u2020.","volume":"25","author":"Mathoulin-P\u00e9lissier","year":"2014","journal-title":"Ann Oncol"},{"key":"R42-20250527","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2354.2005.00640.x","article-title":"Changing trends in the number of deaths from soft tissue sarcoma in Japan, 1955-2002.","volume":"15","author":"Ohtsuka","year":"2006","journal-title":"Eur J Cancer Care (Engl)"},{"key":"R43-20250527","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejso.2017.09.015","article-title":"Treatment challenges in and outside a network setting: soft tissue sarcomas.","volume":"45","author":"Pasquali","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"R44-20250527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CEJ.0000000000000639","article-title":"Cancer mortality and predictions for 2020 in selected Australasian countries, Russia and Ukraine.","volume":"30","author":"Pizzato","year":"2021","journal-title":"Eur J Cancer Prev"},{"key":"R45-20250527","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/annonc\/mdh058","article-title":"Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas.","volume":"15","author":"Ray-Coquard","year":"2004","journal-title":"Ann Oncol"},{"key":"R46-20250527","doi-asserted-by":"crossref","first-page":"c7170","DOI":"10.1136\/bmj.c7170","article-title":"Diagnosis and management of soft tissue sarcoma.","volume":"341","author":"Sinha","year":"2010","journal-title":"BMJ"},{"key":"R47-20250527","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1002\/cncr.33181","article-title":"Patient and diagnostic intervals of survivors of sarcoma: results from the SURVSARC study.","volume":"126","author":"Soomers","year":"2020","journal-title":"Cancer"},{"key":"R48-20250527","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.canep.2018.08.010","article-title":"Survival of adults with cancers of bone or soft tissue in Europe-Report from the EUROCARE-5 study.","volume":"56","author":"Stiller","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"R49-20250527","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejca.2012.09.011","article-title":"Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project.","volume":"49","author":"Stiller","year":"2013","journal-title":"Eur J Cancer"},{"key":"R50-20250527","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/ijc.22239","article-title":"Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases.","volume":"119","author":"Toro","year":"2006","journal-title":"Int J Cancer"},{"key":"R51-20250527","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.canep.2019.02.012","article-title":"Soft tissue sarcoma in Italy: from epidemiological data to clinical networking to improve patient care and outcomes.","volume":"59","author":"Trama","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"R52-20250527","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1016\/S1470-2045(17)30099-2","article-title":"Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts.","volume":"18","author":"van der Graaf","year":"2017","journal-title":"Lancet Oncol"},{"key":"R53-20250527","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.6004\/jnccn.2020.0058","article-title":"NCCN guidelines insights: soft tissue Sarcoma, version 1.2021.","volume":"18","author":"von Mehren","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"R56-20250527","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/annonc\/mdn664","article-title":"Trends in cancer mortality in Japanese adolescents and young adults aged 15\u201329 years, 1970\u20132006.","volume":"20","author":"Yang","year":"2009","journal-title":"Ann Oncol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:01:37Z","timestamp":1748361697000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000768","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,3]]}}}